LX-1001 | Interleukin Related interleukin-related.com

Product Name :
LX-1001

Search keywords :
ApoE

drugId :
null

Target Vo:
Apolipoprotein E

Target Vo Short Name :
APOE

Moa_Name:
Apolipoprotein E gene transference

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
LEXEO Therapeutics

Active Company_Name :
LEXEO Therapeutics

Active Indication_Name:
Alzheimer Disease

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
TBK1 Rabbit mAb custom synthesis
Bim Rabbit mAb custom synthesis
CD144/VE Cadherin Antibody: CD144/VE Cadherin Antibody is an unconjugated, approximately 86 kDa, rabbit-derived, anti-CD144/VE Cadherin polyclonal antibody. CD144/VE Cadherin Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, rat, background without labeling.

Author: Interleukin Related

Related Posts